FDA product code OZQ: Automated Insulin Dosing Device System, Bihormonal Control

OZQ is the FDA product code for automated insulin dosing device system, bihormonal control. It is a Class III device, reviewed by the Clinical Chemistry panel. Devices under OZQ reach the market by PMA; FDA lists no cleared 510(k)s for it.

Definition

A bihormonal automated insulin dosing system that achieves a target glucose level by automatically adjusting two glucose modulating therapies from an infusion pump. Hormone adjustments are based upon specified thresholds of measured glucose levels.

Classification

FieldValue
Device nameAutomated Insulin Dosing Device System, Bihormonal Control
Device classClass III
Review panelCH — Clinical Chemistry
Medical specialtyUnknown
Premarket routePMA

Recalls for OZQ devices

FDA recall records list no recalls for product code OZQ.

Frequently asked questions

What is FDA product code OZQ?

OZQ is the FDA product code for automated insulin dosing device system, bihormonal control. It is a Class III device, reviewed by the Clinical Chemistry panel.

What device class is OZQ?

Class III. Typical premarket route: PMA.

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Clinical Chemistry product codes · FDA product code lookup · 510(k) database search · 510(k) review times